
BusinessLead story
OpenAI researcher Miles Wang in talks to raise $200M for drug discovery startup at $2B valuation
Lightspeed is in discussions to lead the round as Wang and other OpenAI researchers leave to build AI models for drug repurposing.
Jaeden SchaferEditor in Chief4 min read